financetom
ANGO
financetom
/
Healthcare
/
ANGO
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
AngioDynamics, Inc.ANGO
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

AngioDynamics, Inc. provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally.

It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease.

The company's thrombus management portfolio includes AlphaVac system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac circuit is indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure.

In addition, it offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures.

The company also provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators.

AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Latest News >
Applovin Insider Sold Shares Worth $809,268, According to a Recent SEC Filing
Applovin Insider Sold Shares Worth $809,268, According to a Recent SEC Filing
Mar 12, 2024
04:26 PM EDT, 03/12/2024 (MT Newswires) -- Katie Kihorany Jansen, Chief Marketing Officer, on March 08, 2024, sold 12,650 shares in Applovin ( APP ) for $809,268. Following the Form 4 filing with the SEC, Jansen has control over a total of 1,418,354 shares of the company, with 1,264,284 shares held directly and 154,070 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1751008/000156218024002597/xslF345X03/primarydocument.xml Price:...
Applovin Insider Sold Shares Worth $1,625,000, According to a Recent SEC Filing
Applovin Insider Sold Shares Worth $1,625,000, According to a Recent SEC Filing
Mar 12, 2024
04:26 PM EDT, 03/12/2024 (MT Newswires) -- Victoria Valenzuela, Chief Legal Officer and Corporate Secretary, on March 08, 2024, sold 25,000 shares in Applovin ( APP ) for $1,625,000. Following the Form 4 filing with the SEC, Valenzuela has control over a total of 521,560 shares of the company, with 521,560 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1751008/000156218024002596/xslF345X03/primarydocument.xml Price: 61.85, Change:...
Coinbase Global Insider Sold Shares Worth $5,458,750, According to a Recent SEC Filing
Coinbase Global Insider Sold Shares Worth $5,458,750, According to a Recent SEC Filing
Mar 12, 2024
04:30 PM EDT, 03/12/2024 (MT Newswires) -- Lawrence J Brock, Chief People Officer, on March 08, 2024, sold 21,835 shares in Coinbase Global ( COIN ) for $5,458,750. Following the Form 4 filing with the SEC, Brock has control over a total of 13,556 shares of the company, with 13,556 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1679788/000167978824000039/xslF345X03/wk-form4_1710275332.xml Price: 247.57, Change: -8.57,...
Lemaitre Vascular Insider Sold Shares Worth $309,684, According to a Recent SEC Filing
Lemaitre Vascular Insider Sold Shares Worth $309,684, According to a Recent SEC Filing
Mar 12, 2024
04:27 PM EDT, 03/12/2024 (MT Newswires) -- Trent G Kamke, Senior Vice President, Operations, on March 08, 2024, sold 4,542 shares in Lemaitre Vascular ( LMAT ) for $309,684. Following the Form 4 filing with the SEC, Kamke has control over a total of 4,561 shares of the company, with 4,561 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1158895/000143774924007457/xslF345X03/rdgdoc.xml ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved